NeurogeneNGNE

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$471.3M

Market Cap • 03/05/2024

2018

(há 6 anos)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of US

New York

Sede • New York

Valuation

Valuation Indicators

Retorno Histórico

NGNESó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

6%

1 dia

30/04/2024

22%

1 semana

26/04/2024

-17%

1 mês

03/04/2024

108%

1 ano

03/05/2023

-32%

5 anos

03/05/2019

10 anos

Histórico